234 related articles for article (PubMed ID: 3034416)
1. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
Autrup H; Seremet T; Wakhisi J; Wasunna A
Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
[TBL] [Abstract][Full Text] [Related]
2. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
3. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
4. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
Ding ZR
Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
Yeh FS; Yu MC; Mo CC; Luo S; Tong MJ; Henderson BE
Cancer Res; 1989 May; 49(9):2506-9. PubMed ID: 2539905
[TBL] [Abstract][Full Text] [Related]
7. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Harris CC; Sun TT
Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
[TBL] [Abstract][Full Text] [Related]
8. Aflatoxin, viral hepatitis and primary liver cancer.
Stora C; Dvorackova I
J Med; 1987; 18(1):23-41. PubMed ID: 3036991
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
Yeh FS; Mo CC; Yen RC
Natl Cancer Inst Monogr; 1985 Dec; 69():47-8. PubMed ID: 3010122
[TBL] [Abstract][Full Text] [Related]
12. HBsAg, aflatoxins and primary hepatocellular carcinoma.
Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
[TBL] [Abstract][Full Text] [Related]
13. Detection of exposure to aflatoxin in an African population.
Autrup H; Wakhisi J
IARC Sci Publ; 1988; (89):63-6. PubMed ID: 3143673
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis B virus infection and aflatoxin exposure in the development of primary liver cancer].
Lu P; Kuang S; Wang J
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):340-2. PubMed ID: 10923435
[TBL] [Abstract][Full Text] [Related]
15. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
[TBL] [Abstract][Full Text] [Related]
17. [Interaction among the relative risk factors of primary liver cancer in a case-control study].
Zhao N; Yu S; Sun WM
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):90-3. PubMed ID: 7923340
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of hepatocellular carcinoma].
Okuda K
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1105-15. PubMed ID: 8751796
[TBL] [Abstract][Full Text] [Related]
20. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
